Mezion Acquires Additional $163.5 Million Shares of U.S. Subsidiary... Equity Conversion for Financial Soundness Purpose
Mezzion announced on the 16th that it will additionally acquire 158 shares of its U.S. subsidiary Mezzion Pharmaceuticals, Inc. for approximately 163.5 billion KRW.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Worried You Might Be Out"... Trump Sends Another Perfume Named After Himself to Syrian President
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
After acquiring the shares, the ownership stake will be 100%. The acquisition method is the conversion of loan claims into equity, and the purpose of the acquisition is to improve financial soundness.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
